Recent funding opportunities and notices
This alert links to all of the Funding Opportunity Announcements and Notices published by the National Institute on Aging at NIH in the previous month, giving researchers and trainees a heads up about what’s new.
Read about the latest NIA Funding Opportunities (published in February 2022) by clicking on the links below:
- PAR-22-110: NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U24 Clinical Trial Not Allowed)
- RFA-AG-23-005: Health Equity and the Cost of Novel Treatments for Alzheimer’s Disease and Related Dementias (R61/R33 Clinical Trial Not Allowed)
- RFA-AG-23-010: Noncoding RNAs in Alzheimer’s Disease and Related Dementias (R01 Clinical Trial Not Allowed)
- RFA-AG-23-011: Noncoding RNAs in Alzheimer’s Disease and Related Dementias (R21 Clinical Trial Not Allowed)
- RFA-AG-23-014: Mechanisms of Brain Hypoperfusion in AD/ADRD (R01 Clinical Trial Not Allowed)
- RFA-AG-23-007: Screening for Cognitive Impairment: Decision-Making (U24 Clinical Trial Optional)
- RFA-AG-23-012: Inter-Organelle Communication as a Platform to Interrogate the Interactions of Hallmarks of Aging (R01 Clinical Trial Not Allowed)
- RFA-AG-23-013: Mapping Interconnectivity Among Hallmarks of Aging under Lifespan Modifications (R01 Clinical Trial Not Allowed)
- RFA-AG-23-015: Studies of Cytosolic DNAs in the Interactions of Aging Hallmarks (R01 Clinical Trial Not Allowed)
Notices
- NOT-AG-22-014: Notice of Special Interest: Administrative Supplements for HIV/AIDS and Aging Research
- NOT-AG-22-015: Notice to Clarify the Research Objectives of PAR-21-360 “Pilot Studies for the Spectrum of Alzheimer’s Disease/Alzheimer’s Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)”
- NOT-AG-22-017: Notice of Participation of the National Institute on Aging (NIA) in NOT-OD-22-058, Notice of Special Interest (NOSI): Discovery of the Genetic Basis of Conditions Associated with Down Syndrome for the INCLUDE Project (X01)
- NOT-AG-22-009: NIA Caenorhabditis Intervention Testing Program (CITP) Announces A Call for Compounds to Test for Anti-Aging Activity in Caenorhabditis
- NOT-OD-22-057: Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship
Last Updated on March 22, 2022
